Published in J Crohns Colitis on December 24, 2012
On the physician-completed and the patient-completed simple clinical colitis activity index (SCCAI). J Crohns Colitis (2013) 1.04
The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi-center design and study protocol (KL!C- study). BMC Psychiatry (2012) 0.80
Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study. J Crohns Colitis (2016) 0.79
Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol (2016) 0.79
Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility. Am J Physiol Gastrointest Liver Physiol (2016) 0.76
Reply to Drs. Walmsley and Casey letter. J Crohns Colitis (2013) 0.75
Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland. Prz Gastroenterol (2017) 0.75
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Laparoscopy in combination with fast track multimodal management is the best perioperative strategy in patients undergoing colonic surgery: a randomized clinical trial (LAFA-study). Ann Surg (2011) 7.50
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet (2008) 3.11
Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull (2008) 2.87
Understanding self-rated health. Lancet (2002) 2.70
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol (2009) 2.64
Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology (2002) 2.45
The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol (2002) 2.25
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med (2008) 2.23
The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res (2006) 2.08
A meta-analysis of spurious associations between type D personality and cardiovascular disease endpoints. Ann Behav Med (2012) 2.08
Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol (2013) 2.00
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97
Physical and rehabilitation medicine and self-management education: a comparative analysis of two approaches. J Rehabil Med (2010) 1.94
The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol (2002) 1.84
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol (2012) 1.84
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. J Surg Oncol (2006) 1.82
Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol (2010) 1.78
Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. Hum Mol Genet (2010) 1.78
Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69
Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med (2014) 1.69
Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2? Eur J Gastroenterol Hepatol (2008) 1.63
Comparing higher order models for the EORTC QLQ-C30. Qual Life Res (2011) 1.60
A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet (2011) 1.54
An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery. Qual Life Res (2005) 1.53
The importance and impact of social support on outcomes in patients with heart failure: an overview of the literature. J Cardiovasc Nurs (2005) 1.49
Depression and the usefulness of a disease management program in heart failure: insights from the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study. J Am Coll Cardiol (2010) 1.48
Reflections on genes and sustainable change: toward a trait and state conceptualization of response shift. J Clin Epidemiol (2009) 1.48
Invited commentary: personality as a causal factor in cancer risk and mortality--time to retire a hypothesis? Am J Epidemiol (2010) 1.46
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival. Eur J Heart Fail (2006) 1.45
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis. J Crohns Colitis (2012) 1.43
Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study. Liver Int (2014) 1.43
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology (2013) 1.39
Methods to detect response shift in quality of life data: a convergent validity study. Qual Life Res (2005) 1.39
Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol (2009) 1.37
Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs). Trials (2014) 1.34
Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes (2010) 1.34
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol (2012) 1.29
Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations. Ther Drug Monit (2003) 1.28
Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest Endosc (2010) 1.27
Guidelines for improving the stringency of response shift research using the thentest. Qual Life Res (2010) 1.27
Are the most distressing concerns of patients with inoperable lung cancer adequately assessed? A mixed-methods analysis. J Clin Oncol (2010) 1.25
Depressive symptoms as predictors of mortality in patients with COPD. Chest (2008) 1.25
Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol (2007) 1.23
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis (2012) 1.21
Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease. Gastroenterology (2010) 1.21
Lack of prognostic value of type D personality for mortality in a large sample of heart failure patients. Psychosom Med (2011) 1.21
Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis (2007) 1.20
Caregiver burden in partners of Heart Failure patients; limited influence of disease severity. Eur J Heart Fail (2007) 1.18
Enhanced provider communication and patient education regarding return to work in cancer survivors following curative treatment: a pilot study. J Occup Rehabil (2006) 1.14
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology (2014) 1.13
Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin Gastroenterol Hepatol (2006) 1.13
A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol (2008) 1.12
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health Qual Life Outcomes (2010) 1.11
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (2013) 1.11
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer (2013) 1.10
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol (2009) 1.09
Adjustment to cancer in the 8 years following diagnosis: a longitudinal study comparing cancer survivors with healthy individuals. Soc Sci Med (2006) 1.08
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One (2010) 1.07
Change of perspective: a measurable and desired outcome of chronic disease self-management intervention programs that violates the premise of preintervention/postintervention assessment. Arthritis Rheum (2006) 1.07
Formal definitions of measurement bias and explanation bias clarify measurement and conceptual perspectives on response shift. J Clin Epidemiol (2009) 1.06
Ineffectiveness of reverse wording of questionnaire items: let's learn from cows in the rain. PLoS One (2013) 1.05
Autobiographical memory in the euthymic phase of recurrent depression. J Abnorm Psychol (2006) 1.05
Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol (2013) 1.05
Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. Antivir Ther (2010) 1.05
Type of social support matters for prediction of posttraumatic growth among cancer survivors. Psychooncology (2010) 1.05
Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One (2010) 1.04
Effects of a brief intervention program for patients with cancer and their partners on feelings of inequity, relationship quality and psychological distress. Psychooncology (2004) 1.04
Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions. Inflamm Bowel Dis (2015) 1.04
Prediction of recurrence in recurrent depression: a 5.5-year prospective study. J Clin Psychiatry (2010) 1.03
Quality of life and survival in patients with heart failure. Eur J Heart Fail (2012) 1.03
Depression in older people after fall-related injuries: a prospective study. Age Ageing (2003) 1.02
Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur Radiol (2009) 1.02
Depressive symptoms and outcomes in patients with heart failure: data from the COACH study. Eur J Heart Fail (2009) 1.02
HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients. AIDS Behav (2012) 1.01
Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease. Inflamm Bowel Dis (2013) 1.00
Perceived sexual difficulties and associated factors in patients with heart failure. Am Heart J (2012) 0.99
Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival. Eur J Heart Fail (2005) 0.99
Validation of the Chinese version of the EORTC colorectal cancer-specific quality-of-life questionnaire module (QLQ-CR38). J Pain Symptom Manage (2007) 0.99
Critical factors affecting quality of life of adult patients with anorectal malformations or Hirschsprung's disease. Am J Gastroenterol (2004) 0.99
The objective burden in partners of heart failure patients; development and initial validation of the Dutch Objective Burden Inventory. Eur J Cardiovasc Nurs (2007) 0.99
Small-cell lung cancer patients are just 'a little bit' tired: response shift and self-presentation in the measurement of fatigue. Qual Life Res (2007) 0.98
The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol (2008) 0.98
Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences. Thromb Haemost (2004) 0.98
Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology (2011) 0.98
Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance. Ther Drug Monit (2002) 0.97
Combining autofluorescence imaging and narrow-band imaging for the differentiation of adenomas from non-neoplastic colonic polyps among experienced and non-experienced endoscopists. Am J Gastroenterol (2009) 0.97
Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology (2009) 0.97
Course of distress in breast cancer patients, their partners, and matched control couples. Ann Behav Med (2008) 0.97